Heron Therapeutics Inc (NASDAQ:HRTX)

23.80
Delayed Data
As of Feb 16
 -0.10 / -0.42%
Today’s Change
12.70
Today|||52-Week Range
24.80
+31.49%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close23.90
Today’s open23.80
Day’s range23.60 - 24.40
Volume526,358
Average volume (3 months)980,249
Market cap$1.3B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+26.85%
Earnings growth (next 5 years)+47.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.05-0.82%
BYSIBeyondspring Inc+0.38+1.45%
ZIOPZIOPHARM Oncology In...-0.05-1.29%
TGTXTG Therapeutics Inc-0.45-3.56%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 26, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts